Airi Põder

798 total citations
23 papers, 588 citations indexed

About

Airi Põder is a scholar working on Epidemiology, Microbiology and Rheumatology. According to data from OpenAlex, Airi Põder has authored 23 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 5 papers in Microbiology and 4 papers in Rheumatology. Recurrent topics in Airi Põder's work include Respiratory viral infections research (5 papers), Influenza Virus Research Studies (4 papers) and Cervical Cancer and HPV Research (4 papers). Airi Põder is often cited by papers focused on Respiratory viral infections research (5 papers), Influenza Virus Research Studies (4 papers) and Cervical Cancer and HPV Research (4 papers). Airi Põder collaborates with scholars based in Estonia, United States and United Kingdom. Airi Põder's co-authors include Matti Lehtinen, Gitte Strauss, Dominique Descamps, Court Pedersen, Tiina Petäjä, Gary Dubin, Karin Hardt, H. C. Rümke, Jan Hendrik Richardus and Bart Spiessens and has published in prestigious journals such as New England Journal of Medicine, International Journal of Cancer and Annals of the Rheumatic Diseases.

In The Last Decade

Airi Põder

22 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Airi Põder Estonia	9	360	224	133	111	66	23	588
Jaclyn Bowman United Kingdom	7	293 0.8×	138 0.6×	78 0.6×	20 0.2×	36 0.5×	7	471
Stéphane Grillet Switzerland	12	281 0.8×	119 0.5×	56 0.4×	22 0.2×	41 0.6×	17	447
María Akíko Ishida Brazil	11	233 0.6×	78 0.3×	88 0.7×	26 0.2×	29 0.4×	26	406
Massimo De Paschale Italy	14	453 1.3×	55 0.2×	51 0.4×	34 0.3×	32 0.5×	31	735
S. Fouéré France	12	190 0.5×	151 0.7×	54 0.4×	89 0.8×	30 0.5×	59	615
S M Forster United Kingdom	12	171 0.5×	61 0.3×	39 0.3×	45 0.4×	40 0.6×	24	431
Sandra Yoder United States	15	243 0.7×	227 1.0×	12 0.1×	34 0.3×	33 0.5×	28	595
Lin‐Ye Song United States	9	462 1.3×	185 0.8×	8 0.1×	118 1.1×	19 0.3×	11	636
Sven Grützmeier Sweden	13	242 0.7×	477 2.1×	25 0.2×	31 0.3×	39 0.6×	21	796
Kusum Sharma India	14	97 0.3×	36 0.2×	153 1.2×	162 1.5×	19 0.3×	56	587

Countries citing papers authored by Airi Põder

Since Specialization

Citations

This map shows the geographic impact of Airi Põder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Airi Põder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Airi Põder more than expected).

Fields of papers citing papers by Airi Põder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Airi Põder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Airi Põder. The network helps show where Airi Põder may publish in the future.

Co-authorship network of co-authors of Airi Põder

This figure shows the co-authorship network connecting the top 25 collaborators of Airi Põder. A scholar is included among the top collaborators of Airi Põder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Airi Põder. Airi Põder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martinón‐Torres, Federico, Jacek Wysocki, Leszek Szenborn, et al.. (2023). A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1). Vaccine. 41(21). 3387–3398. 15 indexed citations

Põder, Airi, Jay Meyer, Peter Heymer, et al.. (2023). Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age. Vaccines. 11(10). 1528–1528. 8 indexed citations

Beran, Jiřı́, Humberto Reynales, Airi Põder, et al.. (2021). Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study. The Lancet Infectious Diseases. 21(7). 1027–1037. 33 indexed citations

Cusini, Marco, et al.. (2019). 2018 European guideline on the organization of a consultation for sexually transmitted infections. Journal of the European Academy of Dermatology and Venereology. 33(8). 1452–1458. 7 indexed citations

Rivera, Luis, et al.. (2018). MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial. Vaccine. 36(27). 3967–3975. 8 indexed citations

Patel, Rajul, Jackie Sherrard, Daniel Richardson, & Airi Põder. (2018). The growing and important collaboration between BASHH and IUSTI-Europe. Sexually Transmitted Infections. 94(7). 474–474.

Marzo‐Ortega, Helena, Airi Põder, Filip Van den Bosch, et al.. (2017). FRI0512 Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (156-week) improvements in basdai in psoriatic arthritis patients: pooled results from 3 phase iii, randomized, controlled trials. Annals of the Rheumatic Diseases. 76. 683–684. 2 indexed citations

Cutolo, Maurizio, Roy Fleischmann, Frédéric Lioté, et al.. (2016). A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial. The Journal of Rheumatology. 43(9). 1724–1734. 163 indexed citations

Põder, Airi, Brecht Geeraerts, Himal Lal, et al.. (2016). Immunogenicity and Safety of 2 Doses of an Investigational Herpes Zoster Subunit Vaccine Administered 2, 6 or 12 Months Apart in Adults 50 Years and Older: Results of a Phase III, Randomized, Open-Label, Multicenter Trial. Open Forum Infectious Diseases. 3(suppl_1). 3 indexed citations

10.

Kavanaugh, Arthur, Dafna D. Gladman, Christopher J Edwards, et al.. (2016). THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials. Annals of the Rheumatic Diseases. 75. 346–346. 3 indexed citations

11.

Cunningham, Anthony L., Roman Chlíbek, Javier Díez‐Domingo, et al.. (2015). Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults by Region: Results of the Phase 3 ZOE-50 Trial. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations

12.

Põder, Airi, et al.. (2014). HIV in Europe. Clinics in Dermatology. 32(2). 282–285. 5 indexed citations

13.

Põder, Airi, et al.. (2013). An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10–17 years of age. Vaccine. 32(9). 1121–1129. 14 indexed citations

14.

Radcliffe, K W, et al.. (2012). European guideline for the organization of a consultation for sexually transmitted infections, 2012. International Journal of STD & AIDS. 23(9). 609–612. 17 indexed citations

15.

Petäjä, Tiina, Court Pedersen, Airi Põder, et al.. (2010). Long‐term persistence of systemic and mucosal immune response to HPV‐16/18 AS04‐adjuvanted vaccine in preteen/adolescent girls and young women. International Journal of Cancer. 129(9). 2147–2157. 73 indexed citations

16.

Ross, Jonathan, Patricia García, Jonathan M. Zenilman, et al.. (2009). Summary of Proceedings of the IUSTI Global Challenges Symposium (ISSTDR 2007/10th IUSTI World Congress). International Journal of STD & AIDS. 20(2). 130–134. 1 indexed citations

17.

Pedersen, C, Tiina Petäjä, Gitte Strauss, et al.. (2007). Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.. Journal of Child and Adolescent Mental Health. 40. 564–571. 5 indexed citations

18.

Pedersen, Court, Tiina Petäjä, Gitte Strauss, et al.. (2007). Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant. Journal of Adolescent Health. 40(6). 564–571. 192 indexed citations

19.

Naaber, Paul, Anneli Uusküla, Airi Põder, et al.. (2005). Laboratory Diagnosis of Sexually Transmitted Infections in Estonia in 2001–2002: Shortcomings With Impact on Diagnostic Quality and Surveillance. Sexually Transmitted Diseases. 32(12). 759–764. 13 indexed citations

20.

Põder, Airi & John Bingham. (1999). Sexually Transmitted Infections in Estonia. International Journal of STD & AIDS. 10(10). 669–672. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact